A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir
Christophe Piketty, Laurence Weiss, Lambert Assoumou, Marianne Burgard, Aurélie Mélard, Jean-Michel Ragnaud, Michele Bentata, Pierre-Marie Girard, Christine Rouzioux, Dominique CostagliolaVolume:
82
Année:
2010
Langue:
english
Pages:
10
DOI:
10.1002/jmv.21907
Fichier:
PDF, 173 KB
english, 2010